Literature DB >> 24378048

[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].

B Bachellerie1, S Ruiz2, J-M Conil1, L Crognier1, T Seguin1, B Georges1, O Fourcade1.   

Abstract

Dabigatran is a direct thrombin inhibitor indicated for stroke and systemic embolism prevention in patients with non-valvular atrial fibrillation. No reversal agent exists, but hemodialysis has been proposed as dabigatran removal method. We report a case of an 80-year-old man presenting hemorrhage with dabigatran overdose caused by obstructive acute renal failure. Before nephrostomy, several hemodialysis sessions were necessary to remove dabigatran probably because of its large volume of distribution.
Copyright © 2013 Société française d’anesthésie et de réanimation (Sfar). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Acute renal injury; Dabigatran; Hemodialysis; Hémodialyse; Hémorragie; Insuffisance rénale aiguë; Overdose; Surdosage

Mesh:

Substances:

Year:  2013        PMID: 24378048     DOI: 10.1016/j.annfar.2013.11.011

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  4 in total

Review 1.  Anticoagulant-Related Nephropathy.

Authors:  Sergey Brodsky; John Eikelboom; Lee A Hebert
Journal:  J Am Soc Nephrol       Date:  2018-11-12       Impact factor: 10.121

Review 2.  Enhanced elimination of dabigatran through extracorporeal methods.

Authors:  Nadia I Awad; Luigi Brunetti; David N Juurlink
Journal:  J Med Toxicol       Date:  2015-03

Review 3.  Oral anticoagulants and risk of nephropathy.

Authors:  Vinay Narasimha Krishna; David G Warnock; Nakshatra Saxena; Dana V Rizk
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

4.  Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit.

Authors:  Guillaume Claisse; Xavier Delavenne; Ingrid Masson; Nicolas Maillard; Eric Alamartine; Christophe Mariat
Journal:  Clin Kidney J       Date:  2015-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.